IPP Bureau
Gufic Biosciences to grab a major share of Rs. 3,000 crore lyophilized antibacterial market
By IPP Bureau - June 07, 2022
The company has launched indigenously produced Dual Chamber Bags of global standards in India at a pocket-friendly price
NewAmsterdam Pharma shares new data from Phase 2b ROSE Study
By IPP Bureau - June 07, 2022
82.5% of patients treated at 10mg dose of obicetrapib achieved LDL-c target of <70 mg/dL, compared to 20% of patients treated with placebo
MEI Pharma and Kyowa Kirin report new clinical data on Zandelisib
By IPP Bureau - June 07, 2022
he Phase 2 TIDAL data generated to date continue to highlight zandelisib's therapeutic profile and the potential to benefit patients
PM-JAY public dashboard gets revamped with new features
By IPP Bureau - June 07, 2022
The dashboard will serve as a single source of truth for public and PM-JAY stakeholders providing comprehensive view of scheme’s progress
Lonza launches new non-endotoxin pyrogen detection system
By IPP Bureau - June 07, 2022
The human serum-based system shows reduced interferences when testing for pyrogenicity in more complex drug products, such as in blood-derived therapeutics
Proxygen and Merck collaborates to develop molecular glue degraders
By IPP Bureau - June 06, 2022
The companies will jointly identify and develop molecular glue degraders up to a clinical candidate stage.
FDA publishes ANP’s polymeric drug excipient DMF
By IPP Bureau - June 06, 2022
The DMF#36513 demonstrates ANP’s success in the development of its “Plug and Play” drug delivery platform.
ANI Pharmaceuticals consolidates operation post Novitium acquisition
By IPP Bureau - June 06, 2022
Operations at Oakville, Canada manufacturing plant expected to end by first quarter 2023
APhA appoints Ilisa Bernstein Interim CEO
By IPP Bureau - June 06, 2022
Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA
Apollo Speciality Hospitals, Vanagaram organises vertigo awareness bicycle rally
By IPP Bureau - June 06, 2022
The rally attracted around 250 riders, including professionals and amateurs.
Vivimed Labs posts Q4FY22 consolidated loss at Rs. 18.33 Cr
By IPP Bureau - June 06, 2022
The company has posted net loss of Rs. 67.65 crores for the Financial Year ended March 31, 2022
Aurobindo Pharma Q4 PAT drops 28% to Rs 576 Cr
By IPP Bureau - June 06, 2022
Active pharmaceutical ingredients revenue for the quarter was at Rs 913 crore
Thyrocare opens regional processing lab in Ahmedabad
By IPP Bureau - June 06, 2022
New Regional Processing Lab will serve Ahmedabad and the state of Gujarat
Merck’s pembrolizumab demonstrates improvement in distant metastasis
By IPP Bureau - June 06, 2022
Immune-mediated events and infusion reactions were higher with KEYTRUDA (38% vs 9%, respectively).
India ready for playing global role to provide healthcare services: Mandaviya
By IPP Bureau - June 06, 2022
India is at a key inflexion point of not just ‘Heal in India’ through its vibrant medical value tourism, but also ‘Heal by India’, where our medical professionals can be used to serve not just our country but at the global level.
